Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 19, 2021

SELL
$73.77 - $83.61 $33.7 Million - $38.2 Million
-457,396 Closed
0 $0
Q2 2021

Jul 29, 2021

BUY
$80.5 - $88.01 $795,662 - $869,890
9,884 Added 2.21%
457,396 $36.8 Million
Q1 2021

May 10, 2021

BUY
$76.38 - $86.03 $784,193 - $883,270
10,267 Added 2.35%
447,512 $37.7 Million
Q4 2020

Feb 03, 2021

BUY
$75.39 - $82.36 $426,255 - $465,663
5,654 Added 1.31%
437,245 $35.1 Million
Q3 2020

Oct 22, 2020

BUY
$78.33 - $90.73 $599,459 - $694,356
7,653 Added 1.81%
431,591 $34.7 Million
Q2 2020

Jul 20, 2020

BUY
$78.66 - $94.14 $468,105 - $560,227
5,951 Added 1.42%
423,938 $36.5 Million
Q1 2020

Apr 30, 2020

BUY
$71.57 - $93.3 $1.65 Million - $2.15 Million
23,026 Added 5.83%
417,987 $33.9 Million
Q4 2019

Feb 03, 2020

SELL
$76.7 - $88.45 $31,063 - $35,822
-405 Reduced 0.1%
394,961 $33 Million
Q3 2019

Nov 06, 2019

SELL
$81.4 - $89.78 $2.82 Million - $3.11 Million
-34,655 Reduced 8.06%
395,366 $34.6 Million
Q2 2019

Aug 13, 2019

SELL
$73.44 - $82.41 $909,701 - $1.02 Million
-12,387 Reduced 2.8%
430,021 $35.2 Million
Q1 2019

May 03, 2019

SELL
$64.48 - $81.31 $485,340 - $612,020
-7,527 Reduced 1.67%
442,408 $36 Million
Q4 2018

Feb 12, 2019

SELL
$61.45 - $77.8 $1.01 Million - $1.28 Million
-16,505 Reduced 3.54%
449,935 $29.6 Million
Q3 2018

Nov 07, 2018

SELL
$70.71 - $77.75 $178,472 - $196,241
-2,524 Reduced 0.54%
466,440 $36 Million
Q2 2018

Aug 08, 2018

BUY
$63.43 - $75.41 $29.7 Million - $35.4 Million
468,964 New
468,964 $34.6 Million

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $14.7B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Obermeyer Wood Investment Counsel, Lllp Portfolio

Follow Obermeyer Wood Investment Counsel, Lllp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Obermeyer Wood Investment Counsel, Lllp, based on Form 13F filings with the SEC.

News

Stay updated on Obermeyer Wood Investment Counsel, Lllp with notifications on news.